Æskulapfonden: Financial statements 2022
CVR: 38059629
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Æskulapfonden (CVR 38059629) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 124,667 compared with DKK 1,892,957 the year before. Equity in the 2022 report amounted to DKK 10,010,376. The solvency ratio was 99.9%. The company had 4 employees in the financial year.
- Profit/Loss
- DKK 124,667
- Equity
- DKK 10,010,376
- Total Assets
- DKK 10,020,376
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 125 t. | 10 mio. | 4 |
| 2021 | - | - | 1.9 mio. | 9.9 mio. | 4 |
| 2020 | - | - | 578 t. | 8.1 mio. | 3 |
| 2019 | - | - | 496 t. | 7.5 mio. | 3 |
| 2018 | - | - | 691 t. | 7.1 mio. | 3 |
Official annual report
Keep an eye on Æskulapfonden
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Æskulapfonden has published its annual report for 2021. The net result was DKK 1,892,957.
About Æskulapfonden
Æskulapfonden is a Danish company of the type Erhvervsdrivende fond based in Silkeborg, founded in 2016. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The board consists of Lars Pehrson (chair), Jesper Hollensberg, Jens-Otto Andersen and Klaus Loehr-Petersen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a net result of DKK 256,213 compared with DKK 354,730 the year before. Equity in the 2025 report amounted to DKK 10,833,052.